pirinixic acid has been researched along with Complications of Diabetes Mellitus in 1 studies
pirinixic acid: structure
Excerpt | Relevance | Reference |
---|---|---|
"(-)DRF 2725 (6) is a phenoxazine analogue of phenyl propanoic acid." | 1.31 | (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity. ( Bajji, AC; Chakrabarti, R; Juluri, S; Kalchar, S; Lohray, BB; Lohray, VB; Mamidi, NV; Misra, P; Padakanti, S; Poondra, RR; Rajagopalan, R; Vikramadithyan, RK, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lohray, BB | 1 |
Lohray, VB | 1 |
Bajji, AC | 1 |
Kalchar, S | 1 |
Poondra, RR | 1 |
Padakanti, S | 1 |
Chakrabarti, R | 1 |
Vikramadithyan, RK | 1 |
Misra, P | 1 |
Juluri, S | 1 |
Mamidi, NV | 1 |
Rajagopalan, R | 1 |
1 other study available for pirinixic acid and Complications of Diabetes Mellitus
Article | Year |
---|---|
(-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.
Topics: Animals; Biological Availability; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Hyperlip | 2001 |